Enovis | ENOV - Operating Expenses


Enovis reported $552.78M in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
Alcidion AUD 23.27M 565K Dec/2025
Ambu A/S DKK 1.41B 12M Sep/2026
Amplifon EUR 534.52M 8.4M Sep/2026
Apollo Hospitals Enterprise Ltd INR 66.54B 4.68B Sep/2026
Coloplast 5.19B 185M Dec/2025
Convatec Group USD 1B 518M Dec/2024
Diasorin EUR 245.56M 14.56M Jun/2026
Enovis USD 552.78M 7.73M Sep/2026
Gulf Medical Proj AED 168.72M 14.25M Mar/2026
Hoya 117.83B 56.65B Jun/2026
Max Healthcare Institute Limited 19.95B 959.7M Sep/2026
Med Life RON 809.23M 61.36M Mar/2026
Oriola-kd EUR 46.5M 1.1M Sep/2026
Rede D'or Sao Luiz BRL 11.66B 232.07M Jun/2026
Siemens Healthineers EUR 5.94B 1.12B Sep/2026
Sonova Holding CHF 1.52B 59.9M Dec/2025
Supermax Corporation Bhd MYR 187.31M 19.71M Jun/2026